Chemotherapy of leishmaniasis. Part XI: Synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivativesSURYAWANSHI, S. N; TIWARI, Avinash; CHANDRA, Naveen et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 21, pp 6559-6562, issn 0960-894X, 4 p.Article

Chemotherapy of leishmaniasis. part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agentsCHANDRA, Naveen; PANDEY, Susmita; RAMESH et al.European journal of medicinal chemistry. 2006, Vol 41, Num 6, pp 779-785, issn 0223-5234, 7 p.Article

Antileishmanial agents part-IV : synthesis and antileishmanial activity of novel terpenyl pyrimidinesCHANDRA, Naveen; RAMESH; ASHUTOSH et al.European journal of medicinal chemistry. 2005, Vol 40, Num 6, pp 552-556, issn 0223-5234, 5 p.Article

Chemotherapy of leishmaniasis. Part VII Synthesis and bioevaluation of substituted terpenyl pyrimidinesSURYAWANSHI, S. N; BHAT, B. A; PANDEY, Susmita et al.European journal of medicinal chemistry. 2007, Vol 42, Num 9, pp 1211-1217, issn 0223-5234, 7 p.Article

Intacs for keratoconusWACHLER, Brian S; CHANDRA, Naveen S; CHOU, Brian et al.Ophthalmology (Rochester, MN). 2003, Vol 110, Num 5, pp 1031-1040, issn 0161-6420, 10 p.Article

Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusisCHANDRA, Naveen S; TORRES, Mark F; WINTHROP, Kevin L et al.American journal of ophthalmology. 2001, Vol 132, Num 6, pp 819-830, issn 0002-9394Article